

Page 52
conferenceseries
.com
Volume 6, Issue 6 (Suppl)
OMICS J Radiol, an open access journal
ISSN: 2167-7964
Neuroradiology 2017
October 30 to November 01, 2017
October 30 to November 01, 2017 | San Antonio, USA
2
nd
International Conference on
Neuroscience, Neuroimaging & Interventional Radiology
Advances in the imaging of Alzheimer’s disease
Nadia M Biassou
1
National Institutes of Health, USA
2
George Washington University School of Medicine, USA
A
lzheimer’s disease is a fatal neurodegenerative disease with growing incidence in the world. The US CDC estimates that nearly
15 million Americans will be diagnosed with the disease by the year 2050. Similar statistics are cited for EU, China and Latin
America. It has become a worldwide priority for primary care physicians to accurately evaluate the clinical presentations of their
patients and to identify early neuroimaging biomarkers associated with the disease for increased diagnostic certainty and improved
clinical management. Identifying the earliest neuroimaging biomarkers is becoming an essential and increasingly important role for
the neuroradiologist.
biassoun@cc.nih.gov nadia@jantio.comOMICS J Radiol 2017, 6:6, (Suppl)
DOI: 10.4172/2167-7964-C1-019